US Stock MarketDetailed Quotes
IZTC Invizyne Technologies
- 12.600
- -0.870-6.46%
Close Nov 29 13:00 ET
- 12.600
- 0.0000.00%
Post 17:02 ET
120.06MMarket Cap-23420P/E (TTM)
13.830High12.600Low6.08KVolume13.830Open13.470Pre Close79.74KTurnover0.32%Turnover RatioLossP/E (Static)9.53MShares19.37052wk High-33.33P/B23.63MFloat Cap8.50052wk Low--Dividend TTM1.88MShs Float19.370Historical High--Div YieldTTM9.13%Amplitude8.500Historical Low13.108Avg Price1Lot Size
About Invizyne Technologies Company
Invizyne Technologies, Inc. is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV.
Company Profile
SymbolIZTC
Company NameInvizyne Technologies
Listing DateNov 13, 2024
Issue Price8.00
Founded2019
CEOMr. Michael Heltzen
MarketNASDAQ
Employees29
Fiscal Year Ends12-31
Address750 Royal Oaks Drive,Suite 106
CityMonrovia
ProvinceNevada
CountryUnited States of America
Zip Code91016
Phone1-626-415-1488
Websitehttp://www.invizyne.com
Company Executives
- Name
- Position
- Salary
- Michael Heltzen
- Chief Executive Officer
- --
- Fouad Nawaz
- Vice President, Finance and Principal Accounting Officer
- --
- Dr. Zachary Karl, PhD
- Vice President and Head of Business Development
- --
- Michael Burns
- Executive Vice President, Energy Transition
- --
- Dr. Tyler Korman
- Vice President, Research
- 260.47K
- Dr. Paul Opgenorth
- Vice President, Development
- 251.69K
- Mohammad Hayat
- Chairman of the Board and President
- 277.40K
- Christopher A. Marlett
- Director
- --
- Anthony Digiandomenico
- Director
- --
- James Lalonde
- Independent Director
- --
- Dr. Lon E. Bell,PhD
- Independent Director
- --
- Dr. James U. Bowie
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
